These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8392922)
21. [Pathogenesis of diabetic neuropathies]. Lalau JD; Arlot S; Quichaud J Ann Med Interne (Paris); 1985; 136(6):486-95. PubMed ID: 3909874 [TBL] [Abstract][Full Text] [Related]
22. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats. Berti-Mattera L; Day N; Peterson RG; Eichberg J Metabolism; 1996 Mar; 45(3):320-7. PubMed ID: 8606638 [TBL] [Abstract][Full Text] [Related]
23. Phosphatidylinositol-3-phosphate and inositol phosphates in mitogenesis. Poyner D; Hawkins P; Hanley M Biochem Soc Trans; 1990 Jun; 18(3):450-1. PubMed ID: 2164991 [No Abstract] [Full Text] [Related]
24. Glucocorticoids inhibit formation of inositol phosphates in macrophages. Fitzke E; Dieter P Biochem Biophys Res Commun; 1991 Aug; 178(3):974-9. PubMed ID: 1651724 [TBL] [Abstract][Full Text] [Related]
25. Breakdown of polyphosphoinositides and not phosphatidylinositol accounts for muscarinic agonist-stimulated inositol phospholipid metabolism in rat parotid glands. Downes CP; Wusteman MM Biochem J; 1983 Dec; 216(3):633-40. PubMed ID: 6320795 [TBL] [Abstract][Full Text] [Related]
26. Enhanced arterial contractility to noradrenaline in diabetic rats is associated with increased phosphoinositide metabolism. Abebe W; MacLeod KM Can J Physiol Pharmacol; 1991 Mar; 69(3):355-61. PubMed ID: 1647847 [TBL] [Abstract][Full Text] [Related]